BPC-157
HealingSingleA research peptide studied for its potential role in tissue and gut repair.
How it works
BPC-157 appears to upregulate growth factors and angiogenesis through nitric oxide pathways, promoting capillary formation and accelerating wound healing in animal models. It has shown protective effects on the gastrointestinal lining and modulates several growth-factor receptors (VEGFR2, FGF) involved in tissue regeneration.
Protocol notes
Typical research protocols dose 200–500 mcg once daily subcutaneously near the site of injury for cycles of 4–8 weeks. Some users split the dose twice daily. Cycle off for 2–4 weeks before repeating. Often stacked with TB-500 for synergistic tissue-repair protocols.
Reported side effects
Generally well-tolerated in research literature. Reported issues include injection-site irritation, mild nausea, and rare reports of dizziness.
Additional research notes
Commonly used for gut and tissue repair. Typically dosed at 250–500mcg regardless of weight.